Welcome to the TLDR Biotech newsletter!

Our aim is to be your one-stop source for biotech and pharma updates - all with one daily email.

We’ll likely tweak the exact format and delivery over the next few weeks as we get our feet under us.

So if you have any feedback on what you like (or don’t), we’d love to hear from you!

MINOR HOUSEKEEPING
How these updates are formatted

The newsletter is split into three main sections:

• THE GOOD - good news (eg. fundraises, product approvals)

• THE BAD - negative news (eg. clinical trial failures, layoffs)

• THE UGLY - negative but atypical news (lawsuits, product recalls, scandals)

Within each of the three above parts, there are additional sections for easier navigation:

• Eg. There will be multiple “The Good” sections covering things like Fundraises, Approvals, Partnerships etc.

• There will be also additional tags within these sections (Eg. fundraises may mention Stage, product approvals may mention drug name and disease area.)

See something you want to get into further? Click the Read More (goes out to either a news article or a press release).

THE GOOD
Clinical Trials

J&J “pretzel” drug-device combo delivers positive results
Bladder cancer, mAb, drug-device combo - Read more

CG Oncology delivers positive late-stage trial results
Oncolytic virus, bladder cancer - Read more

LEO Pharma prepares to swoop topical JAK market
Small molecule, topical atopic dermatitis - Read more

THE GOOD
Earnings & Finance

Amgen obesity data launches stock price
Obesity, GLP-1 - Read more

Soleno Therapeutics public offering
Small molecule, Prader-Willi syndome - Read more

Abeona Therapeutics $75M Underwritten Offering
Cell & gene therapy, rare disease - Read more

Arrowhead Pharmaceuticals’ $50M royalty payment
RNA therapeutics - Read more

THE GOOD
Expansions

Abbvie drops $161M for new R&D site, Germany
Oncology, neurology, R&D - Read more

THE GOOD
Fundraises

Karius Therapeutics raises $100M, Series C
Genomic diagnostics, infectious disease - Read more

Transcarent raises $126M, Series D
Healthcare platform, access, AI - Read more

THE GOOD
Opinions

Will it be a biotech IPO summer? - Read more

THE GOOD
Partnerships

Immunity Bio partners with Serum Institute of India
BCG vaccine, fusion protein - Read more

Boehringer Ingelheim partners with Wal-greens
Clinical trials, GLP-1, obesity - Read more

THE GOOD
Politics & Policy

Bipartisan support to address on-going US drug shortages
Drug shortages - Read more

Bipartisan legislation for more menopause research
Funding, menopause - Read more

THE GOOD
Strategic Plans

Novo Nordisk continues increasing Wegovy supply
Obesity, GLP-1 - Read more

THE BAD
Clinical Trials

AEON Biopharma stock tanks on failed Phase 2
Botulinum toxin, chronic migraine - Read more

THE BAD
Opinions

Launching a bird flu vaccine? Still a tall order
Infectious disease, bird flu, vaccine - Read more

THE UGLY
Policy & Politics

FTC wants more info, further delays Novo-Catalent site deal
Antitrust, manufacturing - Read more

Chinese biotech and genomics companies get House mark up
Biosecure - Read more

GSK accused of “price-goug[ing] families.”
Asthma, generics, drug pricing - Read more

You’re all caught up on the latest Pharma & Biotech News!

We want to hear from you! 📣 

Have comments/questions/complaints about this newsletter?
Send us an email - we want your brutally honest feedback. 📝

And if you like this newsletter and think a friend or colleague would benefit, please share this with them! ♻️